225 related articles for article (PubMed ID: 34234119)
1. The molecular basis for SARS-CoV-2 binding to dog ACE2.
Zhang Z; Zhang Y; Liu K; Li Y; Lu Q; Wang Q; Zhang Y; Wang L; Liao H; Zheng A; Ma S; Fan Z; Li H; Huang W; Bi Y; Zhao X; Wang Q; Gao GF; Xiao H; Tong Z; Qi J; Sun Y
Nat Commun; 2021 Jul; 12(1):4195. PubMed ID: 34234119
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into the binding variance of the SARS-CoV-2 spike with human, cat and dog ACE2 proteins.
Zang Y; Li X; Zhao Y; Wang H; Hao D; Zhang L; Yang Z; Yuan X; Zhang S
Phys Chem Chem Phys; 2021 Jun; 23(24):13752-13759. PubMed ID: 34132301
[TBL] [Abstract][Full Text] [Related]
3. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF
J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152
[TBL] [Abstract][Full Text] [Related]
4. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
5. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G
Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin.
Niu S; Wang J; Bai B; Wu L; Zheng A; Chen Q; Du P; Han P; Zhang Y; Jia Y; Qiao C; Qi J; Tian WX; Wang HW; Wang Q; Gao GF
EMBO J; 2021 Aug; 40(16):e107786. PubMed ID: 34018203
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
10. Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants.
Laffeber C; de Koning K; Kanaar R; Lebbink JHG
J Mol Biol; 2021 Jul; 433(15):167058. PubMed ID: 34023401
[TBL] [Abstract][Full Text] [Related]
11. E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies.
Wang WB; Liang Y; Jin YQ; Zhang J; Su JG; Li QM
J Mol Graph Model; 2021 Dec; 109():108035. PubMed ID: 34562851
[TBL] [Abstract][Full Text] [Related]
12. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
13. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
[TBL] [Abstract][Full Text] [Related]
14. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
15. Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility.
Gan HH; Twaddle A; Marchand B; Gunsalus KC
J Mol Biol; 2021 Jul; 433(15):167051. PubMed ID: 33992693
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2.
Yan R; Zhang Y; Li Y; Ye F; Guo Y; Xia L; Zhong X; Chi X; Zhou Q
Cell Res; 2021 Jun; 31(6):717-719. PubMed ID: 33737693
[No Abstract] [Full Text] [Related]
17. Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2.
Rodriguez JH
Sci Rep; 2021 Jun; 11(1):12567. PubMed ID: 34131210
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
Yang R; Han P; Han P; Li D; Zhao R; Niu S; Liu K; Li S; Tian W-X; Gao GF
J Virol; 2024 May; 98(5):e0045124. PubMed ID: 38591877
[TBL] [Abstract][Full Text] [Related]
19. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
Lupala CS; Ye Y; Chen H; Su XD; Liu H
Biochem Biophys Res Commun; 2022 Jan; 590():34-41. PubMed ID: 34968782
[TBL] [Abstract][Full Text] [Related]
20. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.
Dash P; Turuk J; Behera SK; Palo SK; Raghav SK; Ghosh A; Sabat J; Rath S; Subhadra S; Rana K; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Dash S; Parida A; Pati S
Int J Infect Dis; 2021 Mar; 104():491-500. PubMed ID: 33450373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
